Consern Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 31-08-2024
- Paid Up Capital ₹ 3.08 M
as on 31-08-2024
- Company Age 23 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.46 Cr
as on 31-08-2024
- Satisfied Charges ₹ 8.23 Cr
as on 31-08-2024
- Revenue 18.11%
(FY 2023)
- Profit 53.13%
(FY 2023)
- Ebitda 31.62%
(FY 2023)
- Net Worth 52.52%
(FY 2023)
- Total Assets 14.92%
(FY 2023)
About Consern Pharma
The Corporate was formerly known as Consern Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.08 M.
The company currently has active open charges totaling ₹8.46 Cr. The company has closed loans amounting to ₹8.23 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kuljive Mahajan, Seema Mahajan, and Mongi Lal serve as directors at the Company.
- CIN/LLPIN
U24232PB2001PLC024715
- Company No.
024715
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Oct 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Consern Pharma Limited offer?
Consern Pharma Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Blood Pressure Medicine, Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Common Disease Medicines, Anti Smoking Drugs, Brain & Nervous System Drugs, Psychotherapeutic Agents, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup.
Who are the key members and board of directors at Consern Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kuljive Mahajan  | Managing Director | 01-Apr-2004 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Seema Mahajan | Director | 17-Oct-2001 | Current |
| Mongi Lal | Director | 29-Jun-2017 | Current |
Financial Performance of Consern Pharma.
Consern Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.11% increase. The company also saw a substantial improvement in profitability, with a 53.13% increase in profit. The company's net worth Soared by an impressive increase of 52.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Consern Pharma?
In 2023, Consern Pharma had a promoter holding of 94.99% and a public holding of 5.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Consern Cosmoceuticals Private LimitedActive 9 years 5 monthsKuljive Mahajan and Seema Mahajan are mutual person
Consern Bharat Private LimitedActive 1 year 30 daysKuljive Mahajan and Seema Mahajan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 26 Feb 2020 | ₹7.96 Cr | Open |
Others Creation Date: 22 Apr 2019 | ₹5.00 M | Open |
Hdfc Bank Limited Creation Date: 07 Oct 2017 | ₹6.70 Cr | Satisfied |
How Many Employees Work at Consern Pharma?
Consern Pharma has a workforce of 468 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Consern Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Consern Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
